GIMOTI

Product NDC: 72089-307
Requested package NDC: 72089-307-15
11-digit product format: 720890307
Labeler code: 72089
Product ID: 72089-307_4b47dd3d-4a37-e136-e063-6394a90a31ef
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: METOCLOPRAMIDE HYDROCHLORIDE
Dosage form: SPRAY
Route: NASAL
Labeler: Evoke Pharma, Inc.
Application: NDA209388
Marketing category: NDA
Marketing start: 2020-06-19
Substance: METOCLOPRAMIDE HYDROCHLORIDE
Active strength: 15 mg/.07mL
Pharmacologic classes: Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N209388-001	GIMOTI	METOCLOPRAMIDE HYDROCHLORIDE	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL		RLD, RS	2020-06-19

Orange Book patents#

Current patent rows page 1 of 1 · 7 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N209388-001	11020361	2029-12-22	U-2843		2021-06-03
N209388-001	11628150	2029-12-22	U-2843	Drug product	2023-04-25
N209388-001	11813231	2029-12-22	U-2843	Drug product	2023-11-16
N209388-001	12194008	2029-12-22	U-2843		2025-01-27
N209388-001	12194009	2029-12-22	U-2843		2025-01-27
N209388-001	8334281	2030-05-16	U-2843	Drug product	2020-06-29
N209388-001	12377064	2038-11-17	U-2843		2025-08-05

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`c0c555d07b60…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N209388-001	GIMOTI	EQ 15MG BASE/SPRAY	SPRAY, METERED / NASAL	RLD, RS	2020-06-19	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 4 · 131 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N209388-001	11020361	2029-12-22	U-2843		2021-06-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209388-001	11628150	2029-12-22	U-2843	Drug product	2023-04-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209388-001	11813231	2029-12-22	U-2843	Drug product	2023-11-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209388-001	12194008	2029-12-22	U-2843		2025-01-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209388-001	12194009	2029-12-22	U-2843		2025-01-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209388-001	8334281	2030-05-16	U-2843	Drug product	2020-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209388-001	12377064	2038-11-17	U-2843		2025-08-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209388-001	11020361	2029-12-22	U-2843		2021-06-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209388-001	11628150	2029-12-22	U-2843	Drug product	2023-04-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209388-001	11813231	2029-12-22	U-2843	Drug product	2023-11-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209388-001	12194008	2029-12-22	U-2843		2025-01-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209388-001	12194009	2029-12-22	U-2843		2025-01-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209388-001	8334281	2030-05-16	U-2843	Drug product	2020-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209388-001	12377064	2038-11-17	U-2843		2025-08-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209388-001	11020361	2029-12-22	U-2843		2021-06-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209388-001	11628150	2029-12-22	U-2843	Drug product	2023-04-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209388-001	11813231	2029-12-22	U-2843	Drug product	2023-11-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209388-001	12194008	2029-12-22	U-2843		2025-01-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209388-001	12194009	2029-12-22	U-2843		2025-01-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209388-001	8334281	2030-05-16	U-2843	Drug product	2020-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209388-001	12377064	2038-11-17	U-2843		2025-08-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209388-001	11020361	2029-12-22	U-2843		2021-06-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209388-001	11628150	2029-12-22	U-2843	Drug product	2023-04-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209388-001	11813231	2029-12-22	U-2843	Drug product	2023-11-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209388-001	12194008	2029-12-22	U-2843		2025-01-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209388-001	12194009	2029-12-22	U-2843		2025-01-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209388-001	8334281	2030-05-16	U-2843	Drug product	2020-06-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209388-001	11020361	2029-12-22	U-2843		2021-06-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209388-001	11628150	2029-12-22	U-2843	Drug product	2023-04-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209388-001	11813231	2029-12-22	U-2843	Drug product	2023-11-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209388-001	12194008	2029-12-22	U-2843		2025-01-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209388-001	12194009	2029-12-22	U-2843		2025-01-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209388-001	8334281	2030-05-16	U-2843	Drug product	2020-06-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209388-001	11020361	2029-12-22	U-2843		2021-06-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209388-001	11628150	2029-12-22	U-2843	Drug product	2023-04-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209388-001	11813231	2029-12-22	U-2843	Drug product	2023-11-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209388-001	8334281	2030-05-16	U-2843	Drug product	2020-06-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209388-001	11020361	2029-12-22	U-2843		2021-06-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209388-001	11628150	2029-12-22	U-2843	Drug product	2023-04-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209388-001	11813231	2029-12-22	U-2843	Drug product	2023-11-16	`2680178bc6a6…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209388-001	NP	2023-06-19	`5c6f7cd8ea54…`
2023-12-20 04:57 UTC	2023-12	N209388-001	NP	2023-06-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N209388-001	NP	2023-06-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N209388-001	NP	2023-06-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N209388-001	NP	2023-06-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N209388-001	NP	2023-06-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N209388-001	NP	2023-06-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N209388-001	NP	2023-06-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N209388-001	NP	2023-06-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N209388-001	NP	2023-06-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N209388-001	NP	2023-06-19	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N209388-001	NP	2023-06-19	`cb3db0bc1861…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GIMOTI	METOCLOPRAMIDE HYDROCHLORIDE	Evoke Pharma, Inc.	95269b1f-779c-4ca0-9f86-e74e677f9900	2026-02-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 209388 application number: NDA209388 ndc (package): 72089-307-15 ndc (product): 72089-307 ndc11 (package): 72089030715

Additional Listing Data#

Finished product: Yes
Brand name base: GIMOTI
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
METOCLOPRAMIDE HYDROCHLORIDE	15 mg/.07mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
W1792A2RVD	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2380564	Internal RxNorm lookup
2380570	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
95269b1f-779c-4ca0-9f86-e74e677f9900	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
86441fd8-22b8-41db-bb26-c70dffc3923b	Product name	1	20210111
340a6817-217a-4b71-9e83-8e2e60c4b0c5	Product name	1	20150319
1f2c49ec-0a44-8021-ecde-b27ece080b13	Product name	1	20140508
46471181-3fa6-5fcd-1d9f-1bb9d2b06171	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
72089-307-15	GIMOTI	1 in 1 CARTON	SPRAY	1		6
72089-307-15	GIMOTI	9.8 mL in 1 BOTTLE, PUMP	SPRAY	9.8		6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
72089-307	GIMOTI (METOCLOPRAMIDE HYDROCHLORIDE) SPRAY [EVOKE PHARMA, INC.]	2	Current NDC, Legacy NDC, 2 package rows	20210109_95269b1f-779c-4ca0-9f86-e74e677f9900.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
W1792A2RVD	METOCLOPRAMIDE HYDROCHLORIDE	54143-57-6	METOCLOPRAMIDE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2380570	Gimoti 15 MG/ACTUAT Nasal Spray	PSN	95269b1f-779c-4ca0-9f86-e74e677f9900	6
2380564	metoclopramide 15 MG/ACTUAT Nasal Spray	PSN	95269b1f-779c-4ca0-9f86-e74e677f9900	6
2380570	metoclopramide 15 MG/ACTUAT Nasal Spray [Gimoti]	SBD	95269b1f-779c-4ca0-9f86-e74e677f9900	6
2380564	metoclopramide 15 MG/ACTUAT Nasal Spray	SCD	95269b1f-779c-4ca0-9f86-e74e677f9900	6
2380570	Gimoti 15 MG/ACTUAT (equivalent to 17.73 MG/ACTUAT of metoclopramide HCl) Nasal Spray	SY	95269b1f-779c-4ca0-9f86-e74e677f9900	6
2380570	Gimoti 15 MG/ACTUAT Nasal Spray	SY	95269b1f-779c-4ca0-9f86-e74e677f9900	6
2380564	metoclopramide 15 MG/ACTUAT (equivalent to 17.73 MG/ACTUAT of metoclopramide HCl) Nasal Spray	SY	95269b1f-779c-4ca0-9f86-e74e677f9900	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
72089-307-15	72089030715	1 BOTTLE, PUMP in 1 CARTON (72089-307-15) / 9.8 mL in 1 BOTTLE, PUMP	2020-06-19	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GIMOTI	Evoke Pharma, Inc. \| Patheon France SAS \| COSMA S.p.A. \| Intertek \| SGS France \| ACM Pharma	2026-02-20	HUMAN PRESCRIPTION DRUG LABEL	6